anti SARS-CoV-2 hyperimmune equine serum
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for anti SARS-CoV-2 hyperimmune equine serum, covering 2021-05-21 to 2021-05-21. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Three Different Doses of an Anti SARS-CoV-2 Hyperimmune Equine Serum in COVID-19 Patients [Phase 2, Phase 3]